Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2

Inhibitors of viral cell entry based on poly(styrene sulfonate) and its core–shell nanoformulations based on gold nanoparticles are investigated against a panel of viruses, including clinical isolates of SARS‐CoV‐2. Macromolecular inhibitors are shown to exhibit the highly sought‐after broad‐spectru...

Descripción completa

Detalles Bibliográficos
Autores principales: Groß, Rüdiger, Dias Loiola, Lívia Mesquita, Issmail, Leila, Uhlig, Nadja, Eberlein, Valentina, Conzelmann, Carina, Olari, Lia‐Raluca, Rauch, Lena, Lawrenz, Jan, Weil, Tatjana, Müller, Janis A., Cardoso, Mateus Borba, Gilg, Andrea, Larsson, Olivia, Höglund, Urban, Pålsson, Sandra Axberg, Tvilum, Anna Selch, Løvschall, Kaja Borup, Kristensen, Maria M., Spetz, Anna‐Lena, Hontonnou, Fortune, Galloux, Marie, Grunwald, Thomas, Zelikin, Alexander N., Münch, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284172/
https://www.ncbi.nlm.nih.gov/pubmed/35543527
http://dx.doi.org/10.1002/advs.202201378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284172/
https://www.ncbi.nlm.nih.gov/pubmed/35543527
http://dx.doi.org/10.1002/advs.202201378

Ejemplares similares